<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The authors are reporting the course of 30 <z:mp ids='MP_0003579'>ovarian carcinomas</z:mp> treated between january 1st 1982 and june 30th 1985, in the department of Medicine and <z:hpo ids='HP_0002664'>Oncology</z:hpo> of the General Hospital in Brazzaville </plain></SENT>
<SENT sid="1" pm="."><plain>They analyze the chemotherapies instituted for the treatment of epithelial, germinal <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> as well as Burkitt's <z:hpo ids='HP_0002665'>lymphomas</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>The prognosis of <z:e sem="disease" ids="C1140680" disease_type="Neoplastic Process" abbrv="">ovarian cancer</z:e> remains extremely poor since 19 patients died, 6 were lost to follow-up and considered as dead, and out of 5 living patients after 10 months, only 2 were in complete remission </plain></SENT>
</text></document>